Alastair Buchan
0000-0002-2918-5200
Oxford University
350 papers found
Refreshing results…
The Canadian activase for stroke effectiveness study
Intra-arterial thrombolysis for hyperacute stroke - Reply
Neuroprotection achieved with a novel proteasome inhibitor which blocks NF-kappa B activation
Apoptosis after experimental stroke: fact or fashion?
Transient forebrain ischemia and fetal hippocampal cell transplantation: effects of early and late prolonged mild hypothermia
NXY-059, a novel free radical trapping agent, reduces cortical infarction after permanent focal ischaemia in rats
Intravenous administration of a novel caspase inhibitor affords neuroprotection following focal ischemia in rats
Time to treatment in the Canadian activase for stroke effectiveness study (CASES): Interim analysis
Maturation of ischemic neuronal death following focal cerebral ischemia
Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats.
Indefatigable protection with prolonged mild hypothermia following experimental focal cerebralischemia in rats
Do caspase and proteasome inhibitors influence the delayed maturation of cortical infarction by preventing apoptosis or neuroinflammation?
Animal models.
Delayed postischemic hypothermia attenuates downregulation of the AMPA receptor subunit, GluR2, in hippocampal CA1
Proscript 519, proteasome inhibitor, reduces cortical neuronal injury following focal ischemia in rats
The hyperdense Sylvian fissure branch sign: A marker of acute CT ischemia
Evaluation of acute stroke with high field MR
The validity and reliability of a novel quantitative CT score in predicting outcome prior to thrombolytic treatment
Interim analysis of the Canadian activase for stroke effectiveness study: Outcome depends on time to treatment
Intravenous administration of a novel free radical trapping agent reduces cortical infarction after permanent focal ischemia in rats
Missing publications? Search for publications with a matching author name.